Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phuoc T Tran

Showing results (1-10 of 245) with videos related to

Pageof 25
Sort By:
Clinical Advances in Hematology & Oncology : H&O|October 2, 2024
Management of oligometastatic hormone-sensitive prostate cancerPhuoc T Tran
Molecular & Cellular Oncology|February 22, 2019
Author's view: epithelial plasticity metabolically reprograms normal cells towards a neoplastic-prone stateHailun Wang, Phuoc T Tran
World Journal of Urology|November 10, 2019
Developments in oligometastatic hormone-sensitive prostate cancerPhuoc T Tran, Piet Ost
Nature Reviews. Urology|February 3, 2016
Prostate cancer: Case volume and improved outcomes across cancer careAmol K Narang, Phuoc T Tran
International Journal of Radiation Oncology, Biology, Physics|December 4, 2023
SABR Today . . . and Tomorrow?Phuoc T Tran, Kent W Mouw
Cancer Biology & Therapy|January 23, 2009
The current STATe of biomarkers to predict the response to anti-angiogenic therapiesPhuoc T Tran, Dean W Felsher
Cancer Journal (Sudbury, Mass.)|March 25, 2020
Oligometastatic and Oligoprogression Disease and Local Therapies in Prostate CancerMatthew P Deek, Phuoc T Tran
Journal of Oncology Practice|January 4, 2017
Altering the Natural History of Oligometastatic Prostate Cancer With Local Therapies: Reality Versus IllusionPhuoc T Tran, Emmanuel S Antonarakis
International Journal of Radiation Oncology, Biology, Physics|May 4, 2018
Live to SABR Another Day?Phuoc T Tran, Felix Feng, Piet Ost
Future Oncology (London, England)|October 12, 2017
What role does stereotactic ablative radiotherapy have in advanced castrate-resistant prostate cancer?Ryan Phillips, Piet Ost, Phuoc T Tran
Pageof 25

Showing results (1-10 of 245) with videos related to

Sort By:
Pageof 25
Clinical Advances in Hematology & Oncology : H&O|October 2, 2024
Management of oligometastatic hormone-sensitive prostate cancerPhuoc T Tran
Molecular & Cellular Oncology|February 22, 2019
Author's view: epithelial plasticity metabolically reprograms normal cells towards a neoplastic-prone stateHailun Wang, Phuoc T Tran
World Journal of Urology|November 10, 2019
Developments in oligometastatic hormone-sensitive prostate cancerPhuoc T Tran, Piet Ost
Nature Reviews. Urology|February 3, 2016
Prostate cancer: Case volume and improved outcomes across cancer careAmol K Narang, Phuoc T Tran
International Journal of Radiation Oncology, Biology, Physics|December 4, 2023
SABR Today . . . and Tomorrow?Phuoc T Tran, Kent W Mouw
Cancer Biology & Therapy|January 23, 2009
The current STATe of biomarkers to predict the response to anti-angiogenic therapiesPhuoc T Tran, Dean W Felsher
Cancer Journal (Sudbury, Mass.)|March 25, 2020
Oligometastatic and Oligoprogression Disease and Local Therapies in Prostate CancerMatthew P Deek, Phuoc T Tran
Journal of Oncology Practice|January 4, 2017
Altering the Natural History of Oligometastatic Prostate Cancer With Local Therapies: Reality Versus IllusionPhuoc T Tran, Emmanuel S Antonarakis
International Journal of Radiation Oncology, Biology, Physics|May 4, 2018
Live to SABR Another Day?Phuoc T Tran, Felix Feng, Piet Ost
Future Oncology (London, England)|October 12, 2017
What role does stereotactic ablative radiotherapy have in advanced castrate-resistant prostate cancer?Ryan Phillips, Piet Ost, Phuoc T Tran
Pageof 25